-
1
-
-
0028889993
-
Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups
-
Zittoun R.A., Mandelli F., Willemze R., de Witte T., Labar B., Resegotti L., et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995, 332:217-223.
-
(1995)
N Engl J Med
, vol.332
, pp. 217-223
-
-
Zittoun, R.A.1
Mandelli, F.2
Willemze, R.3
de Witte, T.4
Labar, B.5
Resegotti, L.6
-
2
-
-
67049164836
-
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials
-
Koreth J., Schlenk R., Kopecky K.J., Honda S., Sierra J., Djulbegovic B.J., et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 2009, 301:2349-2361.
-
(2009)
JAMA
, vol.301
, pp. 2349-2361
-
-
Koreth, J.1
Schlenk, R.2
Kopecky, K.J.3
Honda, S.4
Sierra, J.5
Djulbegovic, B.J.6
-
3
-
-
13544257121
-
Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age
-
Alyea E.P., Kim H.T., Ho V., Cutler C., Gribben J., DeAngelo D.J., et al. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. Blood 2005, 105:1810-1814.
-
(2005)
Blood
, vol.105
, pp. 1810-1814
-
-
Alyea, E.P.1
Kim, H.T.2
Ho, V.3
Cutler, C.4
Gribben, J.5
DeAngelo, D.J.6
-
4
-
-
38949190551
-
Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor
-
Majhail N.S., Brunstein C.G., Tomblyn M., Thomas A.J., Miller J.S., Arora M., et al. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant 2008, 14:282-289.
-
(2008)
Biol Blood Marrow Transplant
, vol.14
, pp. 282-289
-
-
Majhail, N.S.1
Brunstein, C.G.2
Tomblyn, M.3
Thomas, A.J.4
Miller, J.S.5
Arora, M.6
-
5
-
-
73249115577
-
Similar outcomes using myeloablative versus reduced intensity and non-myeloablative allogeneic transplant preparative regimens for AML or MDS: from the center for international blood and marrow transplant research
-
[Abstract 348]
-
Luger S., Ringden O., Perez W.S., Zhang M.-J., DiPersio J.F., Sierra J., et al. Similar outcomes using myeloablative versus reduced intensity and non-myeloablative allogeneic transplant preparative regimens for AML or MDS: from the center for international blood and marrow transplant research. Blood 2008, 112. [Abstract 348].
-
(2008)
Blood
, vol.112
-
-
Luger, S.1
Ringden, O.2
Perez, W.S.3
Zhang, M.-J.4
DiPersio, J.F.5
Sierra, J.6
-
6
-
-
34848855770
-
Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis
-
Flynn C.M., Hirsch B., Defor T., Barker J.N., Miller J.S., Wagner J.E., et al. Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis. Am J Hematol 2007, 82:867-872.
-
(2007)
Am J Hematol
, vol.82
, pp. 867-872
-
-
Flynn, C.M.1
Hirsch, B.2
Defor, T.3
Barker, J.N.4
Miller, J.S.5
Wagner, J.E.6
-
7
-
-
33750205692
-
Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome
-
Alyea E.P., Kim H.T., Ho V., Cutler C., DeAngelo D.J., Stone R., et al. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 2006, 12:1047-1055.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 1047-1055
-
-
Alyea, E.P.1
Kim, H.T.2
Ho, V.3
Cutler, C.4
DeAngelo, D.J.5
Stone, R.6
-
8
-
-
33746661102
-
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes
-
Martino R., Iacobelli S., Brand R., Jansen T., van Biezen A., Finke J., et al. Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. Blood 2006, 108:836-846.
-
(2006)
Blood
, vol.108
, pp. 836-846
-
-
Martino, R.1
Iacobelli, S.2
Brand, R.3
Jansen, T.4
van Biezen, A.5
Finke, J.6
-
9
-
-
38349195008
-
Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission
-
Martino R., Valcarcel D., Brunet S., Sureda A., Sierra J. Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission. Bone Marrow Transplant 2008, 41:33-38.
-
(2008)
Bone Marrow Transplant
, vol.41
, pp. 33-38
-
-
Martino, R.1
Valcarcel, D.2
Brunet, S.3
Sureda, A.4
Sierra, J.5
-
10
-
-
0027941369
-
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B
-
Mayer R.J., Davis R.B., Schiffer C.A., Berg D.T., Powell B.L., Schulman P., et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med 1994, 331:896-903.
-
(1994)
N Engl J Med
, vol.331
, pp. 896-903
-
-
Mayer, R.J.1
Davis, R.B.2
Schiffer, C.A.3
Berg, D.T.4
Powell, B.L.5
Schulman, P.6
-
11
-
-
0034663034
-
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission
-
Tallman M.S., Rowlings P.A., Milone G., Zhang M.J., Perez W.S., Weisdorf D., et al. Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. Blood 2000, 96:1254-1258.
-
(2000)
Blood
, vol.96
, pp. 1254-1258
-
-
Tallman, M.S.1
Rowlings, P.A.2
Milone, G.3
Zhang, M.J.4
Perez, W.S.5
Weisdorf, D.6
-
12
-
-
31344460389
-
Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission
-
Tallman M.S., Perez W.S., Lazarus H.M., Gale R.P., Maziarz R.T., Rowe J.M., et al. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant 2006, 12:204-216.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 204-216
-
-
Tallman, M.S.1
Perez, W.S.2
Lazarus, H.M.3
Gale, R.P.4
Maziarz, R.T.5
Rowe, J.M.6
-
13
-
-
70349256226
-
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
-
Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937-951.
-
(2009)
Blood
, vol.114
, pp. 937-951
-
-
Vardiman, J.W.1
Thiele, J.2
Arber, D.A.3
Brunning, R.D.4
Borowitz, M.J.5
Porwit, A.6
-
14
-
-
0037114753
-
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
-
Byrd J.C., Mrozek K., Dodge R.K., Carroll A.J., Edwards C.G., Arthur D.C., et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002, 100:4325-4336.
-
(2002)
Blood
, vol.100
, pp. 4325-4336
-
-
Byrd, J.C.1
Mrozek, K.2
Dodge, R.K.3
Carroll, A.J.4
Edwards, C.G.5
Arthur, D.C.6
-
15
-
-
23944440464
-
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
-
Sorror M.L., Maris M.B., Storb R., Baron F., Sandmaier B.M., Maloney D.G., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005, 106:2912-2919.
-
(2005)
Blood
, vol.106
, pp. 2912-2919
-
-
Sorror, M.L.1
Maris, M.B.2
Storb, R.3
Baron, F.4
Sandmaier, B.M.5
Maloney, D.G.6
-
16
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
17
-
-
0000336139
-
Regression models and life-tables
-
Cox D.R. Regression models and life-tables. J R Stat Soc B - Methodological 1972, 34:187-220.
-
(1972)
J R Stat Soc B - Methodological
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
18
-
-
1542532754
-
A proportional hazards model for the subdistribution of a competing risk
-
Jason P.F., Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
-
(1999)
J Am Stat Assoc
, vol.94
, pp. 496-509
-
-
Jason, P.F.1
Gray, R.J.2
-
19
-
-
42949142189
-
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
-
Schlenk R.F., Dohner K., Krauter J., Frohling S., Corbacioglu A., Bullinger L., et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008, 358:1909-1918.
-
(2008)
N Engl J Med
, vol.358
, pp. 1909-1918
-
-
Schlenk, R.F.1
Dohner, K.2
Krauter, J.3
Frohling, S.4
Corbacioglu, A.5
Bullinger, L.6
|